Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

Hiddo J.L. Heerspink; Tom Greene; Hocine Tighiouart; Ron T. Gansevoort; Josef Coresh; Andrew Simon; Tak Mao Chan; Fan Fan Hou; Julia B. Lewis; Francesco Locatelli; Manuel Praga; Francesco Paolo Schena; Andrew S. Levey; Lesley A. Inker; Ángel Sevillano; Anne‐Lise Kamper; Arjan D. van Zuilen; Barry M. Brenner; Bart Maes; Benno U. Ihle; Brendan Barret; Leung Cb; Cheuk‐Chun Szeto; Christina Fitzner; Christoph Wanner; Claudio Pozzi; Claudio Ponticelli Montagnino; Di Xie; Dick de Zeeuw; Edmund J. Lewis; Eduardo Verde; Eduardo Gutiérrez; Enyu Imai; Fan Fan Hou; Fernando Caravaca‐Fontán; Fernando C. Fervenza; Francesco Locatelli; Francesco Paolo Schena; Fumiaki Kobayashi; Gabriella Moroni; Gavin J. Becker; Gerald J. Beck; Gerald B. Appel; Gershon Frisch; GG van Essen; Giuseppe Maschio; Giuseppe Remuzzi; Giuseppe Montogrino; Hans‐Henrik Parving; Hiddo J.L. Heerspink; Hirofumi Makino; Imitiaz Jehan; Jack F.M. Wetzels; James V. Donadío; Jamie P. Dwyer; Jan A.J.G. van den Brand; John W. Kusek; John M. Lachin; José Luño; Julia B. Lewis; Jürgen Floege; Kaleab Z. Abebe; K.-M. Chow; Lawrence G. Hunsicker; Lucia Del Vecchio; Manno Carlo; Manuel Praga; Marián Goicoechea; Maximilian von Eynatten; Neil Poulter; Nish Chaturvedi; Patrizia Passerini; Paul E. de Jong; Peter J. Blankestijn; Philip H. Li; Piero Ruggenenti; P Zucchelli; Priscilla Kincaid‐Smith; R.-D Hilgers; Raymond O. Estacio; Richard D. Rohde; Ritsuko Katafuchi; Robert D. Toto; Robert W. Schrier; Roger A. Rodby; Ronald D. Perrone; Sadayoshi Ito; Saulo Klahr; Simeone Andrulli; Svend Strandgaard; Tak Mao Chan; Thierry Hannedouche; Thomas Rauen; Tom Greene; Úrsula Verdalles; Vlado Perkovic; William F. Keane

doi:10.1016/s2213-8587(18)30314-0

Related publications

Article2025

A meta-analysis of albuminuria as a surrogate endpoint for kidney failure

Hiddo J.L. Heerspink, Willem Collier, Juhi Chaudhari, Shiyuan Miao, Hocine Tighiouart, Gerald B. Appel, Fernando Caravaca‐Fontán, Jürgen Floege, Thierry Hannedouche, Enyu Imai, Tazeen H. Jafar, Julia B. Lewis, Philip Kam‐Tao Li, Francesco Locatelli, Bart Maes, Brendon L. Neuen, Vlado Perkovic, Ronald D. Perrone, Giuseppe Remuzzi, Francesco Paolo Schena, Christoph Wanner, Tom Greene, Lesley A. Inker

Article2023

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

Lesley A. Inker, Willem Collier, Tom Greene, Shiyuan Miao, Juhi Chaudhari, Gerald B. Appel, Sunil V. Badve, Fernando Caravaca‐Fontán, Lucia Del Vecchio, Jürgen Floege, Marián Goicoechea, Benjamin Haaland, William G. Herrington, Enyu Imai, Tazeen H. Jafar, Julia B. Lewis, Philip Kam‐Tao Li, Bart Maes, Brendon L. Neuen, Ronald D. Perrone, Giuseppe Remuzzi, Francesco Paolo Schena, Christoph Wanner, Jack F.M. Wetzels,

Article2025

Evaluating Minimal Residual Disease Negativity as a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta‐Analysis of Randomized Controlled Trials

Ioannis Ntanasis‐Stathopoulos, Charalampos Filippatos, Anastasios Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Efstathios Kastritis, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos, Maria Gavriatopoulou

Article2016

Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease

Tobias F. Kröpelin, Dick de Zeeuw, Giuseppe Remuzzi, Rudy Bilous, Hans‐Henrik Parving, Hiddo J.L. Heerspink

Article2024

Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma

Meletios A Dimopoulos, Pieter Sonneveld, Salomon Manier, Annette Lam, Tito Roccia, Jordan M. Schecter, Patricia Cost, Lida Pacaud, Abbey E. Poirier, Gabriel Tremblay, Tommy Lan, Satish Valluri, Shaji Kumar